The inhibitory effect of photodynamic therapy and of an anti-VCAM-1 monoclonal antibody on the in vivo growth of C6 glioma xenografts

Brazilian Journal of Medical and Biological Research

Volumn 44, Issue 5, 2011, Pages 489-496

  Zhan, Qi ^a   Yue, Wu ^a   Hu, Shaoshan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Anti VCAM 1 monoclonal antibody; Apoptosis; C6 glioma cells; Hematoporphyrin monomethyl ether; Photodynamic therapy

Indexed keywords

HEMATOPORPHYRIN DERIVATIVE; HEMATOPORPHYRIN MONOMETHYL ETHER; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1 MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GLIOMA; MALE; NONHUMAN; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; RAT; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR XENOGRAFT; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

EID: 79958072560     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2011007500052     Document Type: Article

References (36)

1. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 2008; 26: 1338-1345.
2. Hirschberg H, Sun CH, Krasieva T, Madsen SJ. Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells. Lasers Surg Med 2006; 38: 939-945.
3. Madsen SJ, Kharkhuu K, Hirschberg H. Utility of the F98 rat glioma model for photodynamic therapy. J Environ Pathol Toxicol Oncol 2007; 26: 149-155.
4. Beck TJ, Kreth FW, Beyer W, Mehrkens JH, Obermeier A, Stepp H, et al. Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med 2007; 39: 386-393.
5. Akita Y, Kozaki K, Nakagawa A, Saito T, Ito S, Tamada Y, et al. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity. Br J Dermatol 2004; 151: 472-480.
6. Zhu TC, Hahn SM, Kapatkin AS, Dimofte A, Rodriguez CE, Vulcan TG, et al. In vivo optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy. Photochem Photobiol 2003; 77: 81-88.
7. Maenpaa A, Kovanen PE, Paetau A, Jaaskelainen J, Timonen T. Lymphocyte adhesion molecule ligands and extracellular matrix proteins in gliomas and normal brain: expression of VCAM-1 in gliomas. Acta Neuropathol 1997; 94: 216-225.
8. Salmaggi A, Eoli M, Frigerio S, Ciusani E, Silvani A, Boiardi A. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and plasma thrombomodulin levels in glioblastoma patients. Cancer Lett 1999; 146: 169-172.
9. Ding X, Xu Q, Liu F, Zhou P, Gu Y, Zeng J, et al. Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation. Cancer Lett 2004; 216: 43-54.
10. Song K, Kong B, Qu X, Li L, Yang Q. Phototoxicity of Hemoporfin to ovarian cancer. Biochem Biophys Res Commun 2005; 337: 127-132.
11. Wang JB, Liu LX, Pan SH, Wang CY, Fu QF. Therapeutic effect of photodynamic therapy using hematoporphyrin monomethyl ether (HMME) on human cholangiocarcinoma cell line QBC939. Neoplasma 2010; 57: 79-85.
12. Zelenkov P, Baumgartner R, Bise K, Heide M, Meier R, Stocker S, et al. Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model. J Neurooncol 2007; 82: 49-60.
13. Slack-Davis JK, Atkins KA, Harrer C, Hershey ED, Conaway M. Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis. Cancer Res 2009; 69: 1469-1476.
14. Justicia C, Martin A, Rojas S, Gironella M, Cervera A, Panes J, et al. Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. J Cereb Blood Flow Metab 2006; 26: 421-432.
15. Schreiber S, Gross S, Brandis A, Harmelin A, Rosenbach-Belkin V, Scherz A, et al. Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd-bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery. Int J Cancer 2002; 99: 279-285.
16. Ulmer S, Reeh M, Krause J, Herdegen T, Heldt-Feindt J, Jansen O, et al. Dynamic contrast-enhanced susceptibilityweighted perfusion MRI (DSC-MRI) in a glioma model of the rat brain using a conventional receive-only surface coil with a inner diameter of 47 mm at a clinical 1.5 T scanner. J Neurosci Methods 2008; 172: 168-172.
17. Burton EC, Prados MD. Malignant gliomas. Curr Treat Options Oncol 2000; 1: 459-468.
18. Hu SS, Cheng HB, Zheng YR, Zhang RY, Yue W, Zhang H. Effects of photodynamic therapy on the ultrastructure of glioma cells. Biomed Environ Sci 2007; 20: 269-273.
19. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 1972; 175: 409-416.
20. Zhou Q, Olivo M, Lye KY, Moore S, Sharma A, Chowbay B. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models. Cancer Chemother Pharmacol 2005; 56: 569-577.
21. Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res 2000; 60: 4066-4069.
22. Bhuvaneswari R, Yuen GY, Chee SK, Olivo M. Hypericinmediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins. Photochem Photobiol Sci 2007; 6: 1275-1283.
23. Kosharskyy B, Solban N, Chang SK, Rizvi I, Chang Y, Hasan T. A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer. Cancer Res 2006; 66: 10953-10958.
24. Bhuvaneswari R, Gan YY, Soo KC, Olivo M. Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response. Mol Cancer 2009; 8: 94.
25. Ferrario A, Von Tiehl K, Wong S, Luna M, Gomer CJ. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Cancer Res 2002; 62: 3956-3961.
26. Ferrario A, Fisher AM, Rucker N, Gomer CJ. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res 2005; 65: 9473-9478.
27. Yee KK, Soo KC, Olivo M. Anti-angiogenic effects of Hypericin- photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma. Int J Mol Med 2005; 16: 993-1002.
28. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995; 376: 517-519.
29. Hemmerlein B, Scherbening J, Kugler A, Radzun HJ. Expression of VCAM-1, ICAM-1, E- and P-selectin and tumour-associated macrophages in renal cell carcinoma. Histopathology 2000; 37: 78-83.
30. Garmy-Susini B, Jin H, Zhu Y, Sung RJ, Hwang R, Varner J. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J Clin Invest 2005; 115: 1542-1551.
31. Ding YB, Chen GY, Xia JG, Zang XW, Yang HY, Yang L. Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma. World J Gastroenterol 2003; 9: 1409-1414.
32. Maurer CA, Friess H, Kretschmann B, Wildi S, Muller C, Graber H, et al. Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer. Int J Cancer 1998; 79: 76-81.
33. Duan H, Cheng L, Sun X, Wu Y, Hu L, Wang J, et al. LFA-1 and VLA-4 involved in human high proliferative potentialendothelial progenitor cells homing to ischemic tissue. Thromb Haemost 2006; 96: 807-815.
34. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66: 605-612.
35. Shin J, Kim J, Ryu B, Chi SG, Park H. Caveolin-1 is associated with VCAM-1 dependent adhesion of gastric cancer cells to endothelial cells. Cell Physiol Biochem 2006; 17: 211-220.
36. Lin MI, Yu J, Murata T, Sessa WC. Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res 2007; 67: 2849-2856.